Cargando…

Correction to: Remdesivir for Treatment of COVID-19: Combination of Pulmonary and IV Administration May Offer Additional Benefit

Detalles Bibliográficos
Autor principal:	Sun, Duxin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396203/ https://www.ncbi.nlm.nih.gov/pubmed/32743771 http://dx.doi.org/10.1208/s12248-020-00483-8

Ejemplares similares

Remdesivir for Treatment of COVID-19: Combination of Pulmonary and IV Administration May Offer Aditional Benefit
por: Sun, Duxin
Publicado: (2020)

Pulmonary administration of remdesivir in the treatment of COVID-19
por: Rasmussen, Henrik Berg, et al.
Publicado: (2020)

Correction to: Remdesivir: A Review in COVID-19
por: Blair, Hannah A.
Publicado: (2023)

Correction: Does conservative kidney management offer a quantity or quality of life benefit compared to dialysis? a systematic review
por: Buur, Louise Engelbrecht, et al.
Publicado: (2022)

Publisher Correction: Seasonal forecasts offer economic benefit for hydrological decision making in semi-arid regions
por: Portele, Tanja C., et al.
Publicado: (2021)

Correction to: Adaptation strategies in transnational education: a case study of an australian Master of Health Administration Course offered to chinese managers
por: Liu, Chaojie, et al.
Publicado: (2022)

Publisher Correction: Combination therapy for tuberculosis treatment: pulmonary administration of ethionamide and booster co-loaded nanoparticles
por: Costa-Gouveia, Joana, et al.
Publicado: (2018)

Correction: Combined Treatment of Xenon and Hypothermia in Newborn Rats - Additive or Synergistic Effect?
Publicado: (2014)

Correction to: Plasma concentrations of remdesivir metabolite in a critical COVID-19 patient needing continuous venovenous haemodialysis
por: Tempestilli, Massimo, et al.
Publicado: (2022)

Combined therapy with dapagliflozin and entresto offers an additional benefit on improving the heart function in rat after ischemia-reperfusion injury
por: Ko, Sheung-Fat, et al.
Publicado: (2023)

Benefit-risk assessment for remdesivir in COVID-19
Publicado: (2020)

Correction: Offering Mental Health Services in a Conflict Affected Region of Pakistan: Who Comes, and Why?
Publicado: (2014)

Correction: The benefit of tumor molecular profiling on predicting treatments for colorectal adenocarcinomas
por: Carter, Philip, et al.
Publicado: (2018)

Additions and Corrections
Publicado: (2015)

Remdesivir in Treatment of COVID-19: A Systematic Benefit–Risk Assessment
por: Davies, Miranda, et al.
Publicado: (2020)

Phase IV non-inferiority trials and additional claims of benefit
por: Bernabe, Rosemarie DLC, et al.
Publicado: (2013)

Correction to: Hypoxia treatment of Parkinson’s disease may disrupt the circadian system
por: Coste, Olivier, et al.
Publicado: (2023)

Author Correction: Zebrafish and medaka offer insights into the neurobehavioral correlates of vertebrate magnetoreception
por: Myklatun, Ahne, et al.
Publicado: (2018)

Correction: Multi-level Modeling of Light-Induced Stomatal Opening Offers New Insights into Its Regulation by Drought
Publicado: (2016)

Correction: DHA Supplemented in Peptamen Diet Offers No Advantage in Pathways to Amyloidosis: Is It Time to Evaluate Composite Lipid Diet?
por: Amtul, Zareen, et al.
Publicado: (2017)

Publisher Correction: Metabolites of type I, II, III, and IV collagen may serve as markers of disease activity in axial spondyloarthritis
por: Hušáková, Markéta, et al.
Publicado: (2020)

Correction to: A Method for Tapering Antipsychotic Treatment That May Minimize the Risk of Relapse
Publicado: (2022)

Publisher Correction: Universal probabilistic programming offers a powerful approach to statistical phylogenetics
por: Ronquist, Fredrik, et al.
Publicado: (2021)

Correction: Template-dependent inhibition of coronavirus RNA-dependent RNA polymerase by remdesivir reveals a second mechanism of action
por: Tchesnokov, Egor P., et al.
Publicado: (2021)

Correction: Overall survival of stage IV non-small cell lung cancer patients treated with Viscum album L. in addition to chemotherapy, a real-world observational multicenter analysis
por: Schad, Friedemann, et al.
Publicado: (2022)

Correction to: Improved Survival Among Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Treated With Remdesivir and Dexamethasone. A Nationwide Population-Based Cohort Study
por: Benfield, Thomas, et al.
Publicado: (2022)

Correction: Core decompression combined with local DFO administration loaded on polylactic glycolic acid scaffolds for the treatment of osteonecrosis of the femoral head: a pilot study
por: Gharanizadeh, Kaveh, et al.
Publicado: (2023)

Correction to: Who benefits most from expectancy effects? A combined neuroimaging and antidepressant trial in depressed older adults
por: Zilcha-Mano, Sigal, et al.
Publicado: (2022)

Correction: Abatacept in combination with methotrexate in Japanese biologic-naive patients with active rheumatoid arthritis: a randomised placebo-controlled phase IV study
Publicado: (2019)

Correction to: Trastuzumab administration during pregnancy: an update
por: Andrikopoulou, Angeliki, et al.
Publicado: (2021)

Correction to: Identifying Patients for Self-Administration of Omalizumab
por: Murphy, Kevin R., et al.
Publicado: (2022)

Correction: Carrageenan as a dry strength additive for papermaking
Publicado: (2017)

Correction: Accounting for tourism benefits in marine reserve design
Publicado: (2018)

Correction: Legionella Eukaryotic-Like Type IV Substrates Interfere with Organelle Trafficking
por: de Felipe, Karim Suwwan, et al.
Publicado: (2010)

Correction: Legionella Eukaryotic-Like Type IV Substrates Interfere with Organelle Trafficking
por: de Felipe, Karim Suwwan, et al.
Publicado: (2010)

Early administration of remdesivir may reduce mortality in hospitalized COVID-19 patients: A propensity score matched analysis
por: Karolyi, Mario, et al.
Publicado: (2022)

Correction to: benefit incidence analysis in public health facilities in India: utilization and benefits at the national and state levels
por: Bowser, Diana, et al.
Publicado: (2019)

Remdesivir and COVID-19 infection, therapeutic benefits or unnecessary risks?
por: Vitiello, Antonio, et al.
Publicado: (2021)

Remdesivir use in severe renal impairment: benefits outweigh risks
Publicado: (2021)

Correction to: Administrative Claims Data Versus Augmented Pregnancy Data for the Study of Pharmaceutical Treatments in Pregnancy
por: Andrade, Susan E., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_iscs8u951m16aek4v7fhhkmlrg